Cholinergic treatment of Alzheimer's disease and its influence on health and the quality of life of carers

Neuroscience and Behavioral Physiology

Volumn 41, Issue 5, 2011, Pages 542-547

  Kolykhalov, I V ^a   Rassadina, G A ^b   Gavrilova, S I ^a   Gerasimov, N P ^b  

^a MENTAL HEALTH RESEARCH CENTER   (Russian Federation)

^b Municipal Clinical Hospital No 7   (Russian Federation)

Author keywords

Alzheimer's disease; caring for patients; cholinergic treatment; quality of life; rivastigmine

Indexed keywords

PROPAZINE; QUETIAPINE; RISPERIDONE; RIVASTIGMINE; TIAPRIDE;

ADL DISABILITY; ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; BEHAVIOR DISORDER; CAREGIVER BURDEN; CAREGIVER SUPPORT; CHOLELITHIASIS; CHOLINERGIC ACTIVITY; CHRONIC PANCREATITIS; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CLINICAL FEATURE; COGNITION; COMBINATION CHEMOTHERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; DOSE RESPONSE; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG SAFETY; DRUG USE; EMOTIONAL STRESS; EPIGASTRIC PAIN; FEMALE; FUNCTIONAL STATUS; HEART DISEASE; HEART RATE; HUMAN; MALE; NAUSEA; OUTCOME ASSESSMENT; PAIN; PATIENT MONITORING; PHYSICAL STRESS; PSYCHOSIS; QUALITY OF LIFE; RISK REDUCTION; SIDE EFFECT; TREATMENT DURATION; VOMITING;

EID: 79959867548     PISSN: 00970549     EISSN: 1573899X     Source Type: Journal    
DOI: 10.1007/s11055-011-9452-3     Document Type: Article

References (17)

1. L. Allan, H. Hays, N. H. Jensen, et al., "Randomised crossover trial of transdermal fentanyl and sustained release oral morphine for treating chronic non-cancer pain," Brit. Med. J., 322, 1154-1158 (2001).
2. "Alzheimer's Association. 2008 Alzheimer's disease facts and figures," Alzheimer's Dementia, 4, No. 2, 110-133 (2008).
3. S. H. Croog, J. A. Burleson, A. Sudilovsky, and R. M. Baume, "Spouse caregivers of Alzheimer patients: problem responses to caregiver burden," Aging Ment. Health, 10, 87-100 (2006).
4. J. L. Cummings, M. Mega, K. Gray, et al., "The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia," Neurology, 44, No. 12, 2308-2314 (1994).
5. C. Donaldson, N. Tarrier, and A. Burns, "Determinants of carer stress in Alzheimer's disease," Int. J. Geriat. Psychiat., 13, 248-256 (1998).
6. M. F. Folstein, S. E. Folstein, and P. R. McHugh, "Mini-Mental State. A practical method of grading the cognitive state of patients for the clinician," J. Psychiat. Res., 12, 189-198 (1975).
7. I. Gelinas, L. Gauthier, and M. McIntyre, "Development of a functional measure for persons with Alzheimer's disease: the Disability Assessment for Dementia," Am. J. Occ. Ther., 53, 471-481 (1999).
8. R. Mahoney, C. Regan, and C. Katona, "Anxiety and depression in family caregivers of people with Alzheimer's disease: the LASER-AD study," Am. J. Geriat. Psychiat., 13, 795-801 (2005).
9. G. McKhann, D. Drachman, M. Folstein, et al., "Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ARDRA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease," Neurology, 146, 939-944 (1984).
10. R. C. Mohs and L. Cohen, "Alzheimer's Disease Assessment Scale (ADAS)," Psychopharmacol. Bull., 24, 627-628 (1988).
11. J. C. Morris, "The Clinical Dementia Rating (CDR). Current version and scoring rules," Neurology, 43, 2412-2413 (1993).
12. K. M. Sink, K. E. Covinsky, and D. E. Barnes, "Caregiver characteristics are associated with neuropsychiatric symptoms of dementia," J. Am. Geriatr. Soc., 54, 796-803 (2006).
13. P. W. Slattum and M. A. Johnson, "Caregiver burden in Alzheimer's disease," Consult. Pharm., 19, 352-362 (2004).
14. H. Takechi, H. Yamada, Y. Sugihara, and T. Kita, "Behavioral and psychological symptoms, cognitive impairment and caregiver burden related to Alzheimer's disease patients treated in an out-patient memory clinic" [in Japanese], Nippon Ronen Igakkai Zasshi, 43, 207-216 (2006).
15. S. S. Travis, H. F. Kao, and G. J. Acton, "Helping family members manage medication administration hassles," J. Psychiat. Ment. Health Nurs., 43, 13-15 (2005).
16. C. Valle-Jones, J. O'Hara, and H. O'Hara, "Comparative clinical trial of the tolerability, patient acceptability and efficacy of two transdermal glyceryl trinitrate patches ('Deponit' 5 and 'Transiderm Nitro' 5) in patients with angina pectoris," Curr. Med. Res. Opin., 11, 331-339 (1989).
17. A. Wimo and G. Nordberg, "Validity and reliability of assessments of time. Comparisons of direct observations and estimates of time by the use of the resource utilization in dementia (RUD) instrument," Arch. Gerontol. Geriat., 4, No. 1, 71-81 (2007).